• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Greenbrook (GBNH) Stock Is Trading Sharply Lower

    2/22/24 11:20:42 AM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care
    Get the next $GBNH alert in real time by email

    Greenbrook TMS Inc (NASDAQ:GBNH) shares are trading lower by 44.5% to $0.21 during Thursday’s session after the company announced a registered direct offering in which institutional investors will purchase 6 million common shares at $0.20 per share.

    This offering will result in gross proceeds of around $1.2 million. The offering is expected to close on February 26, pending customary closing conditions. The net proceeds will be utilized for working capital and general corporate purposes.

    A.G.P./Alliance Global Partners is the sole placement agent for the offering.

    See Also: Japan’s Nikkei 225 Hits Record Highs, But Warren Buffett Is Holding The Applause

    How To Buy GBNH Stock

    By now you're likely curious about how to participate in the market for Greenbrook – be it to purchase shares, or even attempt to bet against the company.

    Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

    In the the case of Greenbrook, which is trading at $0.2 as of publishing time, $100 would buy you 500.0 shares of stock.

    If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

    According to data from Benzinga Pro, GBNH has a 52-week high of $1.84 and a 52-week low of $0.17.

    Get the next $GBNH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GBNH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GBNH
    SEC Filings

    View All

    Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Greenbrook TMS Inc. (0001735948) (Filer)

    3/15/24 3:46:21 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Greenbrook TMS Inc. (0001735948) (Filer)

    3/8/24 3:19:54 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Greenbrook TMS Inc. (0001735948) (Filer)

    3/1/24 4:58:50 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    $GBNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Crish Andrew

    3 - Greenbrook TMS Inc. (0001735948) (Issuer)

    3/8/24 4:51:46 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Elstad Juliana

    3 - Greenbrook TMS Inc. (0001735948) (Issuer)

    2/2/24 4:31:30 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    New insider Madryn Asset Management, Lp claimed ownership of 6,363,636 shares (SEC Form 3)

    3 - Greenbrook TMS Inc. (0001735948) (Issuer)

    1/11/24 9:45:02 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    $GBNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Greybrook Announces Passing of Founder Elias Vamvakas

    TORONTO, July 11, 2024 /CNW/ - It is with heavy hearts that the Executive Team at Greybrook announces the passing of our cherished founder, Elias Vamvakas, today, after a courageous battle with pancreatic cancer. Elias was 65 years old. Elias Vamvakas was a visionary leader whose entrepreneurial spirit and dedication laid the foundation for Greybrook, a distinguished Canadian private equity firm with investments in real estate and health care. Born in 1958 in Athens, Greece, Elias immigrated to Canada in 1966. His journey from an immigrant to a celebrated business leader was a

    7/11/24 1:55:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

    TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

    2/23/24 9:00:00 AM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    Greenbrook Announces $1.2 Million Registered Direct Offering

    TORONTO, Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds for working capital as well as

    2/22/24 8:00:00 AM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    $GBNH
    Financials

    Live finance-specific insights

    View All

    GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

    TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

    2/23/24 9:00:00 AM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

    TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

    2/15/24 5:21:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

    TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

    2/6/24 5:15:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    $GBNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

    SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

    2/28/24 5:22:33 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

    SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

    2/28/24 3:26:24 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

    SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

    10/24/23 4:15:27 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    $GBNH
    Leadership Updates

    Live Leadership Updates

    View All

    GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

    TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

    1/29/24 5:00:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

    TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

    1/23/24 4:31:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

    TORONTO, June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").   The total number of common shares represented at the Meeting was 29,769,721, representing approximately 72.96% of Greenbrook's outstanding common shares entit

    6/20/23 5:00:00 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care